Advancing Understanding of Transportation Options
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Brain Injuries
- Acute Coronary Syndrome
- Arthritis
- Syncope
- Vision Disorders
- Seizures
- Chronic Obstructive Pulmonary Disease
- Orthostatic Hypotension
- Congestive Heart Failure
- Dementia
- Diabetic Retinopathy
- Multiple Sclerosis
- Spinal Cord Injuries
- Vertigo
- Sleep Apnea
- Obstructive Sleep Apnea
- Restless Legs Syndrome
- Macular Degeneration
- Narcolepsy
- Dizziness
- End Stage Renal Disease
- Stroke
- Foot--Abnormalities
- Implantable Defibrillator User
- Retinitis Pigmentosa
- Insomnia
- Substance Use
- Insulin Dependent Diabetes Mellitus
- Glaucoma
- Hypertrophic Obstructive Cardiomyopathy
- Presyncope
- Parkinson Disease
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Single (Outcomes Assessor)Primary Purpose: Health Services Research
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
The investigators will use a multi-site, two-armed randomized controlled trial of older drivers (n=300; ?70 years) from clinical settings, and one family member each (n=up to 300), with longitudinal follow-up. Study goals are to test how much the DDA improves outcomes and identify who benefits most ...
The investigators will use a multi-site, two-armed randomized controlled trial of older drivers (n=300; ?70 years) from clinical settings, and one family member each (n=up to 300), with longitudinal follow-up. Study goals are to test how much the DDA improves outcomes and identify who benefits most from the DDA. Evaluation of the DDA's efficacy (Aim 1) and its relative effect in subgroups (Aim 2) corresponds to Stage II in the NIH Stage Model for Behavioral Intervention Development. Findings from Aims 1 & 2 could identify necessary refinements (Stage I) and inform future efficacy, effectiveness or implementation trials.
Tracking Information
- NCT #
- NCT04141891
- Collaborators
- National Institute on Aging (NIA)
- Investigators
- Principal Investigator: Marian E Betz, MD, MPH University of Colorado - Anschutz Medical Campus
Get Well Soon